NSE filing, NSE: UJJIVANSFB. Summary written from the filing by ALFA Finder's alert engine.
Ujjivan Small Finance Bank Ltd: key numbers
- Share price
- ₹54.50
- Market cap
- ₹10,644 Cr
- Revenue (annual)
- ₹6,931 Cr
- Net profit (annual)
- ₹692.6 Cr
- P/E (TTM)
- 9.3×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 18.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ujjivan Small Finance Bank Ltd
All →Ujjivan Small Finance Bank Earnings Call Transcript: Key Takeaways
Ujjivan SFB delivered an all-time high quarterly PAT of INR365 crores (ROA 2.4%). Strategy shifts toward secured assets (52.1% of book) while maintaining strong collection efficiency (99.7%) and robust deposit growth.
Ujjivan Small Finance Bank Annual General Meeting
Ujjivan Small Finance Bank has convened an Extra-ordinary General Meeting on November 13, 2026, to seek shareholder approval for a preferential issue of equity shares.
Ujjivan Small Finance Bank Preferential Issue
Ujjivan SFB filed EGM notice for a preferential issue of 6.32 crore shares at ₹64.73, raising ₹409 crore. Allottees include IFCA, Bajaj Life, ABSL, and HDFC Life.
- Value
- ₹409.0 Cr
Ujjivan Small Finance Bank Fund Raise of ₹249 Cr
Ujjivan Small Finance Bank executed a subscription agreement with IFC for a preferential issue of shares. The transaction involves raising approximately Rs. 249.04 Crore at Rs. 64.73 per share.
- Value
- ₹249.0 Cr
Ujjivan Small Finance Bank Results Update
Ujjivan Small Finance Bank reported a 200% YoY increase in quarterly PAT to ₹365 Crore. The board also approved a ₹409 Crore capital infusion through preferential allotment.
- Value
- ₹365.0 Cr
- new branches
- 104.0 branches
Ujjivan Small Finance Bank Investor Presentation: Key Takeaways
Ujjivan SFB delivered a record quarterly PAT of ₹365 Cr, driven by strong 35% YoY NII growth. Deposits crossed the ₹50,000 Cr milestone while maintaining a 26% CASA ratio.
- Call
- Guides 25% growth
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.